Coronavirus Update: FDA panel to review Pfizer and Moderna vaccines for children aged six month to 4 years on June 15Market Watch • 05/24/22
Pfizer reports more positive clinical data for its investigational colitis drugMarket Watch • 05/24/22
Everest Medicines' Licensing Partner Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative ColitisPRNewsWire • 05/24/22
Pfizer Presents ELEVATE Pivotal Findings Demonstrating Etrasimod's Potentially Best-in-Class Profile in Ulcerative ColitisBusiness Wire • 05/24/22
FDA panel sets June 15 meeting on Pfizer, Moderna Covid vaccines for infants and toddlersCNBC • 05/23/22
Pfizer/BioNTech say third vaccine dose is 80% effective against Omicron in kids 5 and youngerProactive Investors • 05/23/22
Pfizer, BioNTech COVID-19 vaccine for children aged 6 months to 5 years meets EUA criteriaMarket Watch • 05/23/22
Pfizer Says Three Shots Of Low Dose Vaccine Generates ‘Strong Immune Response' In Kids Under 5Forbes • 05/23/22
Pfizer says third Covid vaccine shot for kids under 5 is 80% effective against omicronCNBC • 05/23/22
Pfizer-BioNTech COVID-19 Vaccine Demonstrates Strong Immune Response, High Efficacy and Favorable Safety in Children 6 Months to Under 5 Years of Age Following Third DoseBusiness Wire • 05/23/22
“I chose to take a gamble”: Husband-wife lab researchers admit taking Pfizer vaccine data to develop their own cancer treatmentMarket Watch • 05/20/22
Pfizer and Moderna saved lives during Covid-19. So why are their stocks crumbling?CNN Business • 05/20/22
CDC advisors just endorsed a booster shot for 5-11s as new Omicron subvariants emergeBusiness Insider • 05/19/22
The Wall Street Journal: CDC advisers recommend Pfizer COVID-19 booster shot for kids ages 5 to 11Market Watch • 05/19/22